FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vicente Carreño

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Physiology

Virus Replication

Co-author Network

Publications

TOP 3
Inmaculada Castillo; Juan A Quiroga; Guillermina Barril; Javier Bartolomé; Vicente Carreño
Long-term virological follow up of patients with occult hepatitis C virus infection.
Guillermina Barril; Javier Bartolomé; Paloma Sanz; Emmanuela Buoncristiani; Juan Antonio Traver; Rafael Selgas; Umberto Buoncristiani; Inmaculada Castillo; Juan Antonio Quiroga; Vicente Carreño
Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels.
Inmaculada Castillo; Javier Bartolomé; Juan A Quiroga; Guillermina Barril; Vicente Carreño
Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vicente Carreño (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Inmaculada Castillo; Juan A Quiroga; Guillermina Barril; Javier Bartolomé; Vicente Carreño
Long-term virological follow up of patients with occult hepatitis C virus infection.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(10):1519-24.
2010: Guillermina Barril; Javier Bartolomé; Paloma Sanz; Emmanuela Buoncristiani; Juan Antonio Traver; Rafael Selgas; Umberto Buoncristiani; Inmaculada Castillo; Juan Antonio Quiroga; Vicente Carreño
Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels.
Journal of medical virology 2010;82(5):763-7.
2009: Inmaculada Castillo; Javier Bartolomé; Juan A Quiroga; Guillermina Barril; Vicente Carreño
Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.
Alimentary pharmacology & therapeutics 2009;30(5):477-86.
2009: Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Hepatitis C virus replication in patients with occult hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2009;49(6):2128-9; author reply 2129.
2009: Juan A Quiroga; Inmaculada Castillo; Silvia Llorente; Javier Bartolomé; Guillermina Barril; Vicente Carreño
Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
Journal of hepatology 2009;50(2):256-63.
2008: Guillermina Barril; Inmaculada Castillo; María Dolores Arenas; Mario Espinosa; Juan Garcia-Valdecasas; Nuria Garcia-Fernández; Emilio González-Parra; José María Alcazar; Carmen Sánchez; José Carlos Diez-Baylón; Pilar Martinez; Javier Bartolomé; Vicente Carreño
Occult hepatitis C virus infection among hemodialysis patients.
Journal of the American Society of Nephrology : JASN 2008;19(12):2288-92.
2008: Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Occult hepatitis B virus and hepatitis C virus infections.
Reviews in medical virology 2008;18(3):139-57.
2007: Javier Bartolomé; Elena Rodríguez-Iñigo; Alejo Erice; Sonia Vidal; Inmaculada Castillo; Vicente Carreño
Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C.
Journal of medical virology 2007;79(12):1818-20.
2007: Juan A Quiroga; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.
Clinical and vaccine immunology : CVI 2007;14(10):1302-6.
2007: Margarita Pardo; Javier Bartolomé; Vicente Carreño
Current therapy of chronic hepatitis B.
Archives of medical research 2007;38(6):661-77.
2007: Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Inmaculada Castillo; M E Castellanos; Margarita Pardo; Javier Bartolomé; Juan A Quiroga; Vicente Carreño
The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy.
Alimentary pharmacology & therapeutics 2007;25(10):1193-201.
2007: Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Javier Bartolomé; Margarita Pardo; Vicente Carreño
Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
Journal of medical virology 2007;79(3):236-41.
2006: Juan A Quiroga; Inmaculada Castillo; Margarita Pardo; Elena Rodríguez-Iñigo; Vicente Carreño
Combined hepatitis C virus (HCV) antigen-antibody detection assay does not improve diagnosis for seronegative individuals with occult HCV infection.
Journal of clinical microbiology 2006;44(12):4559-60.
2006: Vicente Carreño
Occult hepatitis C virus infection: a new form of hepatitis C.
World journal of gastroenterology : WJG 2006;12(43):6922-5.
2006: Juan A Quiroga; Silvia Llorente; Inmaculada Castillo; Elena Rodríguez-Iñigo; Margarita Pardo; Vicente Carreño
Cellular immune responses associated with occult hepatitis C virus infection of the liver.
Journal of virology 2006;80(22):10972-9.
2006: Juan A Quiroga; Silvia Llorente; Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Margarita Pardo; Vicente Carreño
Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Journal of medical virology 2006;78(9):1190-7.
2006: Vicente Carreño; Margarita Pardo; Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Castillo
Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
The Journal of infectious diseases 2006;194(1):53-60.
2006: Margarita Pardo; Juan Manuel López-Alcorocho; Inmaculada Castillo; Elena Rodríguez-Iñigo; A Perez-Mota; Vicente Carreño
Effect of anti-viral therapy for occult hepatitis C virus infection.
Alimentary pharmacology & therapeutics 2006;23(8):1153-9.
2005: Elena Rodríguez-Iñigo; Javier Bartolomé; Nuria Ortiz-Movilla; C Platero; Juan Manuel López-Alcorocho; Margarita Pardo; Inmaculada Castillo; Vicente Carreño
Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.
Journal of virology 2005;79(24):15578-81.
2005: Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Javier Bartolomé; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels.
The Journal of molecular diagnostics : JMD 2005;7(4):535-43.
2005: Elena Rodríguez-Iñigo; Esther Jiménez; Javier Bartolomé; Nuria Ortiz-Movilla; Begoña Bartolomé-Villar; Juan José Arrieta; Félix Manzarbeitia; Vicente Carreño
Detection of human immunodeficiency virus type 1 RNA by in situ hybridization in oral mucosa epithelial cells from anti-HIV-1 positive patients.
Journal of medical virology 2005;77(1):17-22.
2005: Inmaculada Castillo; Elena Rodríguez-Iñigo; Javier Bartolomé; Susana de Lucas; N Ortíz-Movilla; Juan Manuel López-Alcorocho; Margarita Pardo; Vicente Carreño
Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.
Gut 2005;54(5):682-5.
2004: Vicente Carreño; Inmaculada Castillo; Javier Bartolomé; Elena Rodríguez-Iñigo; Nuria Ortiz-Movilla; Susana de Lucas; Margarita Pardo
Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(4):312-3.
2004: Susana de Lucas Sd; Juan Manuel López-Alcorocho; Javier Bartolomé; Vicente Carreño
Nitric oxide and TGF-beta1 inhibit HNF-4alpha function in HEPG2 cells.
Biochemical and biophysical research communications 2004;321(3):688-94.
2004: Luisa Fernanda Mariscal; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Castillo; Nuria Ortiz-Movilla; Cristina Navacerrada; Margarita Pardo; Arturo Pérez-Mota; Javier Graus; Vicente Carreño
Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
Journal of medical virology 2004;73(2):177-86.
2004: Inmaculada Castillo; Margarita Pardo; Javier Bartolomé; Nuria Ortiz-Movilla; Elena Rodríguez-Iñigo; Susana de Lucas; Clara Salas; José A Jiménez-Heffernan; Arturo Pérez-Mota; Javier Graus; Juan Manuel López-Alcorocho; Vicente Carreño
Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
The Journal of infectious diseases 2004;189(1):7-14.
2004: Miguel A Rico; Sara Ruiz; Dolores Subirá; Guillermina Barril; Secundino Cigarrán; Susana Castañón; Juan A Quiroga; Rafael Selgas; Vicente Carreño
Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
Journal of medical virology 2004;72(1):66-74.
2003: Susana de Lucas; Javier Bartolomé; María José Amaro; Vicente Carreño
Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation.
Antiviral research 2003;60(2):117-24.
2003: Mario Fernández; Juan A Quiroga; Vicente Carreño
Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins.
The Journal of general virology 2003;84(Pt 8):2073-82.
2003: Elena Rodríguez-Iñigo; Luisa Fernanda Mariscal; Javier Bartolomé; Inmaculada Castillo; Cristina Navacerrada; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.
Journal of medical virology 2003;70(4):571-80.
2003: Jaime Gosálvez; Nuria Ortiz-Movilla; Altea Gosálbez; Elena Rodríguez-Iñigo; Javier Bartolomé; Vicente Carreño
Improved sensitivity for cell mapping of hepatitis C virus RNA sequences and cellular surface antigens in blood cells.
Laboratory investigation; a journal of technical methods and pathology 2003;83(7):1089-91.
2002: Nuria Ortiz-Movilla; Pablo Lázaro; Elena Rodríguez-Iñigo; Javier Bartolomé; Isabel Longo; Manuel Lecona; Margarita Pardo; Vicente Carreño
Hepatitis C virus replicates in sweat glands and is released into sweat in patients with chronic hepatitis C.
Journal of medical virology 2002;68(4):529-36.
2002: Pablo Lazaro; Javier Olalquiaga; Javier Bartolomé; Nuria Ortiz-Movilla; Elena Rodríguez-Iñigo; Margarita Pardo; Manuel Lecona; Mercedes Pico; Isabel Longo; Patricia García-Morrás; Vicente Carreño
Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C.
The Journal of investigative dermatology 2002;119(4):798-803.
2002: Luisa Fernanda Mariscal; Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Nuria Ortiz-Movilla; Susana de Lucas; Javier Bartolomé; Vicente Carreño
TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells.
Virology 2002;301(1):121-9.
2002: M Cabrerizo; Javier Bartolomé; Vicente Carreño
In vitro infection of human peripheral blood mononuclear cells by a defective hepatitis B virus with a deletion in the PreS1 region of the viral genome.
Journal of viral hepatitis 2002;9(4):265-71.
2002: Miguel A Rico; Juan A Quiroga; Dolores Subirá; Esteban Garcia; Susana Castañón; Matti Sällberg; Geert Leroux-Roels; Ola Weiland; Margarita Pardo; Vicente Carreño
Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.
Journal of hepatology 2002;36(3):408-16.
2002: Vicente Carreño
Present treatment expectations and risks of chronic hepatitis C.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2002;8(2):74-9.
2001: Vicente Carreño; Miguel A Rico; Margarita Pardo; Juan A Quiroga
Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-alpha.
Antiviral research 2001;52(2):147-52.
2001: Moisés Diago; D Suárez; L García-Villarreal; A Castro; A Domínguez; M Pardo; J A del Olmo; F Pérez-Hernández; J Aguilar; Juan A Quiroga; Vicente Carreño
Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C.
Journal of medical virology 2001;64(4):460-5.
2001: Elena Rodríguez-Iñigo; JJ Arrieta; M Casqueiro; Javier Bartolomé; Juan Manuel López-Alcorocho; Nuria Ortiz-Movilla; Félix Manzarbeitia; Margarita Pardo; Vicente Carreño
TT virus detection in oral lichen planus lesions.
Journal of medical virology 2001;64(2):183-9.
2001: Susana de Lucas; Javier Bartolomé; Elena Rodríguez-Iñigo; M Casqueiro; A Millán; M Ruiz-Moreno; Horacio Oliva; Vicente Carreño
Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C.
Journal of medical virology 2001;64(1):1-5.
2001: Elena Rodríguez-Iñigo; Javier Bartolomé; Juan A Quiroga; U Hedner; A Suárez; José F Tomás; Félix Manzarbeitia; C Arocena; ML Manzano; Horacio Oliva; Vicente Carreño
Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(3):193-9.
2001: Juan Manuel López-Alcorocho; Guillermina Barril; Nuria Ortiz-Movilla; Juan Antonio Traver; Javier Bartolomé; P Sanz; Rafael Selgas; Vicente Carreño
Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients.
Journal of medical virology 2001;63(2):103-7.
2001: JJ Arrieta; Elena Rodríguez-Iñigo; Nuria Ortiz-Movilla; Javier Bartolomé; Margarita Pardo; Félix Manzarbeitia; Horacio Oliva; D M Macías; Vicente Carreño
In situ detection of hepatitis C virus RNA in salivary glands.
The American journal of pathology 2001;158(1):259-64.
2001: Miguel A Rico; Juan A Quiroga; Dolores Subirá; Susana Castañón; J M Esteban; Margarita Pardo; Vicente Carreño
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Hepatology (Baltimore, Md.) 2001;33(1):295-300.
2000: Juan Manuel López-Alcorocho; Luisa Fernanda Mariscal; Susana de Lucas; Elena Rodríguez-Iñigo; M Casqueiro; Inmaculada Castillo; Javier Bartolomé; M Herrero; ML Manzano; Margarita Pardo; Vicente Carreño
Presence of TTV DNA in serum, liver and peripheral blood mononuclear cells from patients with chronic hepatitis.
Journal of viral hepatitis 2000;7(6):440-7.
2000: M Fogeda; Juan Manuel López-Alcorocho; Javier Bartolomé; C Arocena; M A Martín; Vicente Carreño
Existence of distinct GB virus C/hepatitis G virus variants with different tropism.
Journal of virology 2000;74(17):7936-42.
2000: J Martín; P De Sequera; Juan A Quiroga; M Rico; M Fernández; C Arocena; Carlos Caramelo; Vicente Carreño
Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease.
Cytokine 2000;12(8):1248-52.
2000: A Madejón; ML Manzano; C Arocena; Inmaculada Castillo; Vicente Carreño
Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands.
Journal of hepatology 2000;32(6):1019-25.
2000: ML Manzano; C Arocena; José F Tomás; U Hedner; Juan A Quiroga; Vicente Carreño
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11 Suppl 1():S95-9.
2000: Elena Rodríguez-Iñigo; M Casqueiro; Javier Bartolomé; Nuria Ortiz-Movilla; Juan Manuel López-Alcorocho; M Herrero; Félix Manzarbeitia; Horacio Oliva; Vicente Carreño
Detection of TT virus DNA in liver biopsies by in situ hybridization.
The American journal of pathology 2000;156(4):1227-34.
2000: Elena Rodríguez-Iñigo; M Casqueiro; S Navas; Javier Bartolomé; Margarita Pardo; Vicente Carreño
Fluorescent "in situ" hybridization of hepatitis C virus RNA in peripheral blood mononuclear cells from patients with chronic hepatitis C.
Journal of medical virology 2000;60(3):269-74.
2000: Vicente Carreño; J Martín; Margarita Pardo; A Brotons; P Anchía; S Navas; M Fernández; C Arocena; Juan A Quiroga
Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis c.
Cytokine 2000;12(2):165-70.
2000: T Cotonat; Juan A Quiroga; Juan Manuel López-Alcorocho; R Clouet; Margarita Pardo; Félix Manzarbeitia; Vicente Carreño
Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Hepatology (Baltimore, Md.) 2000;31(2):502-6.
2000: Guillermina Barril; Javier Bartolomé; Juan Antonio Traver; M Cabrerizo; Rafael Selgas; Vicente Carreño
Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially.
Journal of medical virology 2000;60(2):139-43.
2000: Elena Rodríguez-Iñigo; M Casqueiro; Javier Bartolomé; Antonio Barat; Carlos Caramelo; alberto ortiz; Marta Albalate; Horacio Oliva; ML Manzano; Vicente Carreño
Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases.
Journal of viral hepatitis 2000;7(1):23-9.
2000: Guillermina Barril; Juan Manuel López-Alcorocho; Auxiliadora Bajo; Nuria Ortiz-Movilla; José A Sánchez-Tomero; Javier Bartolomé; Rafael Selgas; Vicente Carreño
Prevalence of TT virus in serum and peripheral mononuclear cells from a CAPD population.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2000;20(1):65-8.
1999: M Cabrerizo; Javier Bartolomé; P De Sequera; Carlos Caramelo; M L Manzano; Vicente Carreño
GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients.
Kidney international 1999;56(3):1120-8.
1999: M Fernández; Juan A Quiroga; J Martín; M Herrero; Margarita Pardo; M A Horisberger; Vicente Carreño
In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus.
The Journal of infectious diseases 1999;180(2):262-7.
1999: M Cabrerizo; Javier Bartolomé; M Otero; M Ruiz-Moreno; Vicente Carreño
Sequence variation of hepatitis B virus precore-core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment.
Journal of medical virology 1999;58(3):208-14.
1999: José F Tomás; E Rodriguez-Iñigo; Javier Bartolomé; Adrián Alegre; José María Fernández-Rañada; Vicente Carreño
Transplantation of allogeneic CD34-selected peripheral stem cells does not prevent transmission of hepatitis C virus from an infected donor.
Bone marrow transplantation 1999;24(1):109-12.
1999: Vicente Carreño; Patrick Marcellin; Stephanos Hadziyannis; J Salmerón; Moisés Diago; G E Kitis; I Vafiadis; S W Schalm; F Zahm; Félix Manzarbeitia; Javier Jiménez; Juan A Quiroga
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
Hepatology (Baltimore, Md.) 1999;30(1):277-82.
1999: Elena Rodríguez-Iñigo; Javier Bartolomé; Susana de Lucas; Félix Manzarbeitia; Margarita Pardo; C Arocena; Jaime Gosálvez; Horacio Oliva; Vicente Carreño
Histological damage in chronic hepatitis C is not related to the extent of infection in the liver.
The American journal of pathology 1999;154(6):1877-81.
1999: J Martín; S Navas; M Fernández; M Rico; Margarita Pardo; Juan A Quiroga; F Zahm; Vicente Carreño
In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients.
Antiviral research 1999;42(1):59-70.
1999: M Fogeda; S Navas; J Martín; M Casqueiro; E Rodríguez; C Arocena; Vicente Carreño
In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus.
Journal of virology 1999;73(5):4052-61.
1999: J Martín; Juan A Quiroga; S Navas; Margarita Pardo; Vicente Carreño
Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells.
Cytokine 1999;11(4):267-73.
1999: María José Amaro; Javier Bartolomé; Vicente Carreño
Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter.
Hepatology (Baltimore, Md.) 1999;29(3):915-23.
1999: M Ruiz-Moreno; M Otero; A Millán; Inmaculada Castillo; M Cabrerizo; Javier Jiménez; Horacio Oliva; S Ramon y Cajal; Vicente Carreño
Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B.
Hepatology (Baltimore, Md.) 1999;29(2):572-5.
1999: Juan Manuel López-Alcorocho; Inmaculada Castillo; José F Tomás; Vicente Carreño
Identification of a novel GB type C virus/hepatitis G virus subtype in patients with hematologic malignancies.
Journal of medical virology 1999;57(1):80-4.
1998: M Cabrerizo; Javier Bartolomé; E R Iñigo; Juan Manuel López-Alcorocho; T Cotonat; Vicente Carreño
Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
Journal of medical virology 1998;56(4):294-9.
1998: Marian Goicoechea; J Martin; P De Sequera; Juan A Quiroga; alberto ortiz; Vicente Carreño; Carlos Caramelo
Role of cytokines in the response to erythropoietin in hemodialysis patients.
Kidney international 1998;54(4):1337-43.
1998: A Madejón; Javier Bartolomé; Vicente Carreño
In vitro inhibition of the hepatitis delta virus replication mediated by interferon and trans-ribozyme or antisense probes.
Journal of hepatology 1998;29(3):385-93.
1998: J Martín; S Navas; Juan A Quiroga; Margarita Pardo; Vicente Carreño
Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients.
Cytokine 1998;10(8):635-44.
1998: Juan A Quiroga; J Martín; S Navas; Vicente Carreño
Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage.
The Journal of infectious diseases 1998;178(1):247-51.
1998: Jaime Gosálvez; Elena Rodríguez-Iñigo; JL Ramiro-Díaz; Javier Bartolomé; José F Tomás; Horacio Oliva; Vicente Carreño
Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis.
Hepatology (Baltimore, Md.) 1998;27(5):1428-34.
1998: alberto ortiz; P De Sequera; Vicente Carreño; C Caramelo
Hepatitis B virus infection.
The New England journal of medicine 1998;338(18):1311; author reply 1312-3.
1998: J Martín; S Navas; Juan A Quiroga; G Colucci; Margarita Pardo; Vicente Carreño
Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection.
Journal of medical virology 1998;54(4):265-70.
1998: S Artillo; G Pastore; A Alberti; M Milella; Teresa Santantonio; Giovanna Fattovich; G Giustina; J C Ryff; M Chaneac; Javier Bartolomé; Vicente Carreño
Double-blind, randomized controlled trial of interleukin-2 treatment of chronic hepatitis B.
Journal of medical virology 1998;54(3):167-72.
1998: S Navas; J Martín; Juan A Quiroga; Inmaculada Castillo; Vicente Carreño
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.
Journal of virology 1998;72(2):1640-6.
1998: Juan Manuel López-Alcorocho; María José Amaro; M Cabrerizo; M Fogeda; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Phylogenetic analysis of hepatitis GB virus type C/hepatitis G virus in Spanish patients with chronic hepatitis B or C virus infection.
Intervirology 1998;41(6):233-7.
1997: Margarita Pardo; Inmaculada Castillo; Horacio Oliva; Angel Fernández-Flores; R Bárcena; M A de Peuter; Vicente Carreño
A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C.
Hepatology (Baltimore, Md.) 1997;26(5):1318-21.
1997: Elena Rodríguez-Iñigo; Javier Bartolomé; Juan Manuel López-Alcorocho; T Contonat; Horacio Oliva; Vicente Carreño
Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
Journal of medical virology 1997;53(1):76-80.
1997: M Cabrerizo; Javier Bartolomé; P De Sequera; Carlos Caramelo; Vicente Carreño
Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff.
Journal of the American Society of Nephrology : JASN 1997;8(9):1443-7.
1997: E Rodriguez-Iñigo; José F Tomás; V Gómez-García de Soria; Javier Bartolomé; Inmaculada Pinilla; María José Amaro; Vicente Carreño; José María Fernández-Rañada
Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study.
Blood 1997;90(3):1326-31.
1997: José F Tomás; E Rodriguez-Iñigo; Javier Bartolomé; A Madejón; M Fogeda; Horacio Oliva; A Moreno; José María Fernández-Rañada; Vicente Carreño
Detection of hepatitis G virus from serum and liver of a patient with long-term liver dysfunction after autologous bone marrow transplantation.
Bone marrow transplantation 1997;19(10):1053-7.
1997: Juan Manuel López-Alcorocho; A Millan; E R García-Trevijano; Javier Bartolomé; M Ruiz-Moreno; M Otero; Vicente Carreño
Detection of hepatitis GB virus type C RNA in serum and liver from children with chronic viral hepatitis B and C.
Hepatology (Baltimore, Md.) 1997;25(5):1258-60.
1997: M Fernández; Juan A Quiroga; J Martín; T Cotonat; Margarita Pardo; M A Horisberger; Vicente Carreño
Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection.
Journal of medical virology 1997;51(4):332-7.
1997: María José Amaro; Javier Bartolomé; Margarita Pardo; T Cotonat; A López-Farré; Vicente Carreño
Decreased nitric oxide production in chronic viral hepatitis B and C.
Journal of medical virology 1997;51(4):326-31.
1997: Marta Albalate; M D López García; A Vázquez; P De Sequera; E Marriott; D Tan; alberto ortiz; Santos Casado; Vicente Carreño; Carlos Caramelo; D G López
Concentrated ascitic fluid reinfusion in cirrhotic patients: a simplified method.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(3):392-8.
1997: Angeles Castro; E Carballo; A Domínguez; Moisés Diago; D Suárez; Juan A Quiroga; Vicente Carreño
Tolerance and efficacy of subcutaneous interferon-beta administered for treatment of chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1997;17(2):65-7.
1997: M Ruíz-Moreno; P Fernández; A Leal; Javier Bartolomé; Inmaculada Castillo; Horacio Oliva; Vicente Carreño
Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.
Pediatrics 1997;99(2):222-5.
1997: Vicente Carreño; Juan A Quiroga
Biological properties of interleukin-12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infection.
Journal of viral hepatitis 1997;4 Suppl 2():83-6.
1997: J M Lopez-Alcorocho; J Bartolome; T Cotonat; Vicente Carreño
Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy.
Journal of viral hepatitis 1997;4 Suppl 1():27-32.
1997: Angeles Castro; D Suárez; L Inglada; E Carballo; A Domínguez; Moisés Diago; J Such; J A Del Olmo; Arturo Pérez-Mota; José Domingo Pedreira; Juan A Quiroga; Vicente Carreño
Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1997;17(1):27-30.
1997: S Navas; Inmaculada Castillo; J Martín; Juan A Quiroga; Javier Bartolomé; Vicente Carreño
Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay.
Journal of clinical microbiology 1997;35(1):317-21.
1996: Carlos Caramelo; Javier Bartolomé; Marta Albalate; P De Sequera; S Navas; T Bermejillo; H Oliva; E Marriott; alberto ortiz; C Ruiz Tuñón; Santos Casado; Vicente Carreño
Undiagnosed hepatitis C virus infection in hemodialysis patients: value of HCV RNA and liver enzyme levels.
Kidney international 1996;50(6):2027-31.
1996: E R García-Trevijano; Juan Manuel López-Alcorocho; M Quintana; F Hernández; Vicente Carreño
HGV in coagulation-factor concentrates.
Lancet 1996;348(9033):1032.
1996: Carlos Caramelo; Marta Albalate; T Bermejillo; S Navas; alberto ortiz; P De Sequera; Santos Casado; Vicente Carreño
Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(9):1792-6.
1996: Juan A Quiroga; T Cotonat; Inmaculada Castillo; Vicente Carreño
Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay.
Journal of medical virology 1996;50(1):16-9.
1996: M Cabrerizo; Javier Bartolomé; M Ruiz-Moreno; M Otero; Juan Manuel López-Alcorocho; Vicente Carreño
Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response.
Pediatric research 1996;39(6):980-4.
1996: Juan A Quiroga; Margarita Pardo; S Navas; J Martín; Vicente Carreño
Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.
The Journal of infectious diseases 1996;173(2):300-5.
1996: Vicente Carreño; Juan A Quiroga
New and forthcoming therapies for viral hepatitis.
Journal of hepatology 1996;24(2 Suppl):74-6.
1995: Juan A Quiroga; J van Binsbergen; C Y Wang; Margarita Pardo; S Navas; C Trines; M Herrero; Vicente Carreño
Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Hepatology (Baltimore, Md.) 1995;22(6):1635-40.
1995: M Pardo; E Marriott; M C Moliner; Juan A Quiroga; Vicente Carreño
Risks and benefits of interferon-alpha in the treatment of hepatitis.
Drug safety : an international journal of medical toxicology and drug experience 1995;13(5):304-16.
1995: Inmaculada Castillo; Javier Bartolomé; M Ruiz-Moreno; V Sanchez; S Navas; Vicente Carreño
Hepatitis C virus genotypes in serum and liver of children with chronic hepatitis C.
Pediatric research 1995;38(4):618-20.
1995: M Ruiz-Moreno; T Camps; J Jimenez; R López; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Factors predictive of response to interferon therapy in children with chronic hepatitis B.
Journal of hepatology 1995;22(5):540-4.
1995: Margarita Pardo; Inmaculada Castillo; S Navas; Vicente Carreño
Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha.
Journal of medical virology 1995;45(4):439-44.
1995: M Pernas; Javier Bartolomé; Inmaculada Castillo; Juan A Quiroga; Margarita Pardo; Vicente Carreño
Sequence of non-structural regions 3 and 5 of hepatitis C virus genomes from Spanish patients: existence of a predominant variant related to type 1b.
The Journal of general virology 1995;76 ( Pt 2)():415-20.
1995: S Navas; O Bosch; Inmaculada Castillo; E Marriott; Vicente Carreño
Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study.
Hepatology (Baltimore, Md.) 1995;21(2):279-84.
1995: S González; S Navas; A Madejón; Javier Bartolomé; Inmaculada Castillo; G Moraleda; J Martín; E Marriott; M Herrero; Vicente Carreño
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C.
Journal of medical virology 1995;45(2):168-73.
1995: J M Lopez-Alcorocho; M Cabrerizo; J Bartolome; T Cotonat; Vicente Carreño
Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon.
Journal of viral hepatitis 1995;2(6):279-84.
1995: Javier Bartolomé; A Madejón; Vicente Carreño
Ribozymes: structure, characteristics and use as potential antiviral agents.
Journal of hepatology 1995;22(1 Suppl):57-64.
1995: S Navas; Vicente Carreño
Semiquantification by Amplicor assay of hepatitis C virus genome during therapy.
Journal of hepatology 1995;22(1 Suppl):115-7.
1995: Vicente Carreño; Juan A Quiroga
Biologic response modifiers in chronic hepatitis C.
Journal of hepatology 1995;22(1 Suppl):122-6.
1994: J Martín; Juan A Quiroga; O Bosch; Vicente Carreño
Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 1994;20(5):1156-61.
1994: Juan A Quiroga; J Martin; M Pernas; Margarita Pardo; M Herrero; Inmaculada Castillo; J Bartolome; Vicente Carreño
Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C.
Clinical and diagnostic laboratory immunology 1994;1(5):545-51.
1994: Vicente Carreño; Javier Bartolomé; A Madejón
Hepatitis delta virus infection: molecular biology and treatment.
Digestive diseases (Basel, Switzerland) 1994;12(5):265-75.
1994: Juan A Quiroga; M Herrero; Inmaculada Castillo; S Navas; Margarita Pardo; Vicente Carreño
Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
The Journal of infectious diseases 1994;170(3):669-73.
1994: S Navas; Inmaculada Castillo; Javier Bartolomé; E Marriott; M Herrero; Vicente Carreño
Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion.
Journal of hepatology 1994;21(2):182-6.
1994: M Pardo; T Cotonat; M Herrero; E Marriott; S Artillo; J A Quiroga; Vicente Carreño
Retreatment of chronic hepatitis C virus infection.
Lancet 1994;343(8912):1568-9.
1994: Inmaculada Castillo; Javier Bartolomé; S Navas; S Gonzalez; M Herrero; Vicente Carreño
Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon.
Hepatology (Baltimore, Md.) 1994;19(6):1342-6.
1994: A Madejón; T Cotonat; Javier Bartolomé; Inmaculada Castillo; Vicente Carreño
Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response.
Hepatology (Baltimore, Md.) 1994;19(6):1331-6.
1994: Vicente Carreño; Javier Bartolomé; Inmaculada Castillo
Long-term effect of interferon therapy in chronic hepatitis B.
Journal of hepatology 1994;20(3):431-5.
1994: Carlos Caramelo; S Navas; M L Alberola; T Bermejillo; A Reyero; Vicente Carreño
Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
Nephron 1994;66(4):470-3.
1993: O Bosch; G Moraleda; Inmaculada Castillo; Vicente Carreño
Treatment of chronic hepatitis B with recombinant interferon alpha versus recombinant interferon alpha plus levamisole.
Journal of hepatology 1993;19(3):437-41.
1993: J Martin; O Bosch; G Moraleda; J Bartolome; Juan A Quiroga; Vicente Carreño
Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.
Hepatology (Baltimore, Md.) 1993;18(4):775-80.
1993: M Ruiz-Moreno; Rosa García; M J Rua; B Serrano; G Moraleda; E Feijoo; Javier Bartolomé; F Ortiz; Inmaculada Castillo; Vicente Carreño
Levamisole and interferon in children with chronic hepatitis B.
Hepatology (Baltimore, Md.) 1993;18(2):264-9.
1993: E Marriott; S Navas; J del Romero; S García; Inmaculada Castillo; Juan A Quiroga; Vicente Carreño
Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients.
Journal of medical virology 1993;40(2):107-11.
1993: Vicente Carreño; A Moreno; F Galiana; F J Bartolomé
Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study.
Journal of hepatology 1993;17(3):321-5.
1993: O Bosch; L Tapia; Juan A Quiroga; Vicente Carreño
An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C.
Journal of hepatology 1993;17(2):146-9.
1993: A Madejón; Inmaculada Castillo; T Cotonat; Vicente Carreño
Significance of low HDV replication levels during the natural history of HDV infection. Long-term follow-up.
Journal of hepatology 1993;17 Suppl 3():S157-60.
1993: Javier Bartolomé; Inmaculada Castillo; Juan A Quiroga; S Navas; Vicente Carreño
Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells.
Journal of hepatology 1993;17 Suppl 3():S90-3.
1993: Vicente Carreño; E Marriott; Juan A Quiroga
Other approaches to the treatment of chronic viral hepatitis.
Journal of hepatology 1993;17 Suppl 3():S127-9.
1993: A Moreno; C J Martínez; Vicente Carreño
Liver biopsy and the etiologic diagnosis of chronic hepatitis.
Journal of hepatology 1993;17 Suppl 3():S112-5.
1992: M Ruiz-Moreno; Vicente Carreño; M J Rúa; T Cotonat; B Serrano; M Santos; E Marriott
Increase in triglycerides during alpha-interferon treatment of chronic viral hepatitis.
Journal of hepatology 1992;16(3):384.
1992: E Marriott; Juan A Quiroga; Vicente Carreño
Retreatment of chronic hepatitis C with interferon-alpha.
The Journal of infectious diseases 1992;166(5):1200-1.
1992: Juan A Quiroga; O Bosch; R Gonzalez; E Marriott; Inmaculada Castillo; J Bartolome; Vicente Carreño
Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
Gastroenterology 1992;103(4):1285-9.
1992: M Ruiz-Moreno; M J Rua; Inmaculada Castillo; M D García-Novo; M Santos; S Navas; Vicente Carreño
Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
Hepatology (Baltimore, Md.) 1992;16(4):882-5.
1992: J Molina; Javier Bartolomé; G Moraleda; M Ruiz-Moreno; M J Rua; A Moreno; Vicente Carreño
Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver.
Journal of medical virology 1992;38(1):11-5.
1992: M Ruiz-Moreno; M J Rúa; G Moraleda; L Guardia; A Moreno; Vicente Carreño
Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
Pediatrics 1992;90(2 Pt 1):254-8.
1992: Vicente Carreño; L Tapia; J C Ryff; Juan A Quiroga; Inmaculada Castillo
Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
Journal of medical virology 1992;37(3):215-9.
1992: Vicente Carreño; Inmaculada Castillo; J Molina; J C Porres; Javier Bartolomé
Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy.
Journal of hepatology 1992;15(1-2):102-6.
1992: M L Campillo; Juan A Quiroga; Javier Bartolomé; G Moraleda; Inmaculada Castillo; Vicente Carreño
Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy.
Journal of clinical microbiology 1992;30(5):1256-61.
1992: Carlos Caramelo; Vicente Carreño; E González Parra; Juan A Quiroga; M P Garrón; E Marriott; alberto ortiz; A Galera; María Dolores López; J C Porres
Positive Elisa 2 is pathologically relevant in Elisa-1-negative patients on hemodialysis.
Nephron 1992;61(4):474.
1991: G Moraleda; Javier Bartolomé; J Molina; Inmaculada Castillo; Vicente Carreño
Analysis of hepatitis B virus DNA, liver disease and influence of antibody to hepatitis C virus in anti-HBe chronic carriers.
Liver 1991;11(6):352-7.
1991: Juan A Quiroga; M L Campillo; I Catillo; Javier Bartolomé; J C Porres; Vicente Carreño
IgM antibody to hepatitis C virus in acute and chronic hepatitis C.
Hepatology (Baltimore, Md.) 1991;14(1):38-43.
1991: M Ruiz-Moreno; M J Rua; J Molina; G Moraleda; A Moreno; J García-Aguado; Vicente Carreño
Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B.
Hepatology (Baltimore, Md.) 1991;13(6):1035-9.
1991: J C Porres; Vicente Carreño; A Moreno; F J Bartolomé
[Reactivation of hepatitis B virus in chronic carriers with anti-HBe].
Revista clínica española 1991;189(2):68-72.
1991: M G Martinez; Inmaculada Castillo; Juan A Quiroga; J C Porres; Vicente Carreño
Detection of serum inhibitory factor for lymphocyte stimulation in chronic viral hepatitis: relationship with the replication level.
Liver 1991;11(1):48-52.
1991: Federico Sáez-Royuela; J C Porres; A Moreno; Inmaculada Castillo; G Martinez; F Galiana; Vicente Carreño
High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.
Hepatology (Baltimore, Md.) 1991;13(2):327-31.
1991: Vicente Carreño; J C Porres; M Ruiz-Moreno; J Gutiez; F J Bartolomé
[A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1991;79(1):24-8.
1991: Vicente Carreño; Juan A Quiroga
Treatment of chronic hepatitis B with alpha-interferon. Present and future.
Journal of hepatology 1991;13 Suppl 1():S2.
1991: Inmaculada Castillo; Javier Bartolomé; A Madejón; M Melero; J C Porres; Vicente Carreño
Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection.
Digestion 1991;48(3):149-56.
1991: M del Mar Escudero; Juan A Quiroga; F J Bartolomé; Vicente Carreño
Analysis of serum pre-S antigens in chronic hepatitis B virus infection in relation to the expression pattern of hepatitis B virus DNA in the liver.
Digestion 1991;49(4):204-11.
1991: A Díez; Juan A Quiroga; M Melero; G Moraleda; Inmaculada Castillo; J C Porres; Vicente Carreño
Detection of antibody to calmodulin in chronic viral hepatitis: lack of correlation with virus replication and hepatocellular damage.
Digestion 1991;49(3):125-33.
1990: G Moraleda; Javier Bartolomé; M G Martinez; J C Porres; Vicente Carreño
Influence of hepatitis delta virus replication in the presence of hepatitis B virus DNA in peripheral blood mononuclear cells.
Hepatology (Baltimore, Md.) 1990;12(6):1290-4.
1990: Javier Bartolomé; G Moraleda; J Molina; F Dominguez; J C Porres; Vicente Carreño
Hepatitis B virus DNA in liver and peripheral blood mononuclear cells during reduction in virus replication.
Gastroenterology 1990;99(6):1745-50.
1990: A Madejón; Inmaculada Castillo; Javier Bartolomé; M Melero; M L Campillo; J C Porres; A Moreno; Vicente Carreño
Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection.
Journal of hepatology 1990;11(3):381-4.
1990: Vicente Carreño; J A Quiroga
[Vaccines against the hepatitis B virus. The outstanding problems].
Revista clínica española 1990;187(5):247-8.
1990: M Z Ibarra; J C Porres; F J Bartolome; M Escudero; Juan A Quiroga; Vicente Carreño
Changes in anti-idiotype antibodies against anti-HBs during recombinant interferon treatment of chronic hepatitis B.
Journal of interferon research 1990;10(4):367-73.
1990: Javier Bartolomé; G Moraleda; M Ruiz-Moreno; J C Porres; Vicente Carreño
Hepatitis B virus DNA patterns in the liver of children with chronic hepatitis B.
Journal of medical virology 1990;31(3):195-9.
1990: Inmaculada Castillo; Javier Bartolomé; Juan A Quiroga; J C Porres; Vicente Carreño
Detection of HBeAg/anti-HBe immune complexes in the reactivation of hepatitis B virus replication among anti-HBe chronic carriers.
Liver 1990;10(2):79-84.
1990: F J Bartolomé; G Moraleda; Inmaculada Castillo; M G Martinez; J C Porres; Vicente Carreño
Presence of HBV-DNA in peripheral blood mononuclear cells from anti-HIV symptomless carriers.
Journal of hepatology 1990;10(2):186-90.
1990: M Ruiz-Moreno; J Jimenez; J C Porres; Javier Bartolomé; A Moreno; Vicente Carreño
A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
Digestion 1990;45(1):26-33.
1990: M Gómez-Rubio; J C Porres; Inmaculada Castillo; Juan A Quiroga; A Moreno; Vicente Carreño
Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group.
Journal of hepatology 1990;11 Suppl 1():S63-7.
1989: A Moreno; S Ramón y Cajal; Mónica Marazuela; Vicente Carreño; José María Milicua; E Cerezo; C Cuesta; Horacio Oliva
Sanded nuclei in delta patients.
Liver 1989;9(6):367-71.
1989: J C Porres; Vicente Carreño; Javier Bartolomé; A Moreno; F Galiana; Juan A Quiroga
Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
Journal of hepatology 1989;9(3):338-44.
1989: M Ruiz-Moreno; T Camps; J G Aguado; J C Porres; Horacio Oliva; Javier Bartolomé; Vicente Carreño
Serological and histological follow up of chronic hepatitis B infection.
Archives of disease in childhood 1989;64(8):1165-9.
1989: J C Porres; Vicente Carreño; Javier Bartolomé; J Gutiez; Inmaculada Castillo
A dynamic study of the intrafamilial spread of hepatitis B virus infection: relation with the viral replication.
Journal of medical virology 1989;28(4):237-42.
1989: M Z Ibarra; I Mora; Javier Bartolomé; J C Porres; Vicente Carreño
Detection of proteins encoded by the pre-S region of hepatitis B virus in the sera of HBsAg carriers: relation to viral replication.
Liver 1989;9(3):153-8.
1989: J C Porres; Vicente Carreño; M Ruíz; J A Marrón; Javier Bartolomé
Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon.
Journal of hepatology 1989;8(3):351-7.
1989: Inmaculada Castillo; Vicente Carreño; F J Bartolomé; J C Porres; I Mora; M I Herrera
Virus-like particles associated with reverse transcriptase activity in acute sporadic non-A,non-B hepatitis.
Digestion 1989;42(1):7-15.
1988: J C Porres; Vicente Carreño; I Mora; J Gutiez; A Moreno; S Ramon y Cajal; J A Marron; Javier Bartolomé
Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
Hepato-gastroenterology 1988;35(6):300-3.
1988: Juan A Quiroga; I Mora; J C Porres; Vicente Carreño
Elevation of 2',5'-oligoadenylate synthetase activity and HLA-I associated beta 2-microglobulin in response to recombinant interferon-gamma administration in chronic HBeAg-positive hepatitis.
Journal of interferon research 1988;8(6):755-63.
1988: M Z Ibarra; I Mora; Juan A Quiroga; Javier Bartolomé; F La Banda; J C Porres; Vicente Carreño
IgG and IgM autoantiidiotype antibodies against antibody to HBsAg in chronic hepatitis B.
Hepatology (Baltimore, Md.) 1988;8(4):775-80.
1988: Javier Bartolomé; Inmaculada Castillo; I Mora; J Gutiez; J C Porres; Vicente Carreño
Different levels of hepatitis B virus replication among hepatitis Be antigen-positive chronic carriers.
Acta virologica 1988;32(3):193-7.
1988: C Bas; Javier Bartolomé; F La Banda; J C Porres; Juan A Quiroga; I Mora; Vicente Carreño
Assessment of hepatitis B virus DNA levels in chronic HBsAg carriers with or without hepatitis delta virus superinfection.
Journal of hepatology 1988;6(2):208-13.
1988: J C Porres; I Mora; J Gutiez; J Bartolome; Juan A Quiroga; C Bas; C Compernolle; J Ordi; A Chocarro; Vicente Carreño
Antiviral effect of recombinant gamma interferon in chronic hepatitis B virus infection: a pilot study.
Hepato-gastroenterology 1988;35(1):5-9.
1988: F La Banda; M Ruiz-Moreno; Vicente Carreño; J Bartolome; J Gutiez; S Ramon y Cajal; A Moreno; I Mora; J Carlos Porres
Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
Lancet 1988;1(8579):250.
1987: L Inglada; J C Porres; F La Banda; I Mora; Vicente Carreño
Anti-IFN-alpha titres during interferon therapy.
Lancet 1987;2(8574):1521.
1987: Vicente Carreño; J C Porres; I Mora; Javier Bartolomé; C Bas; J Gutiez; J Cortés; C Hernández Guio
Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Liver 1987;7(6):325-32.
1987: I Mora; J C Porres; Vicente Carreño
Receptors for polymerized human serum albumin in plasma derived hepatitis B vaccines.
Vaccine 1987;5(4):279-82.
1987: Juan A Quiroga; Javier Bartolomé; Vicente Carreño; I Mora; J C Porres; J Gutiez; C Hernández Guío
[Detection of a class IgM antibody against the core antigen of the hepatitis B virus in patients with chronic infection].
Revista clínica española 1987;181(7):351-5.
1987: Vicente Carreño; J C Porres; I Mora; J Gutiez; Juan A Quiroga; S Ramón y Cajal; Horacio Oliva; C Compernolle; Javier Bartolomé
A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
Antiviral research 1987;8(3):125-37.
1987: Juan A Quiroga; Javier Bartolomé; J C Porres; I Mora; J Gutiez; C Hernández Guio; Vicente Carreño
Identification of different degrees of hepatitis B virus (HBV) replication by serological (HBV-DNAp, HBcAg and HBV-DNA) and histological (HBcAg) methods.
Liver 1987;7(3):169-75.
1987: I Mora; Vicente Carreño; J C Porres; J Gutiez; C H Guio
Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Acta virologica 1987;31(2):116-25.
1987: I Mora; J C Porres; Javier Bartolomé; Juan A Quiroga; J Gutiez; C Hernández Guio; C Bas; Vicente Carreño
Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection.
Journal of hepatology 1987;4(1):29-36.
1987: C Hernández Guio; Vicente Carreño; J C Porres; I Mora
[Non-A, non-B hepatitis].
Revista clínica española 1987;180(2):100-3.
1987: M de Torres; Vicente Carreño; Javier Bartolomé; J C Porres; C Bas; Juan A Quiroga; I Mora
Liver membrane antibodies in chronic delta hepatitis.
Digestion 1987;38(3):171-7.
1987: Juan A Quiroga; I Mora; Vicente Carreño; M I Herrera; J C Porres; W H Gerlich
Inhibition of albumin binding to hepatitis B virions by monoclonal antibody to the preS2 domain of the viral envelope.
Digestion 1987;38(4):212-20.
1986: I Mora; J C Porres; F J Bartolome; C Hernandez Guio; J Gutiez; Vicente Carreño
Receptors for polymerized human serum albumin and other hepatitis B virus markers during acute hepatitis B--predictive value of the outcome of the disease.
Hepato-gastroenterology 1986;33(6):250-4.
1986: I Mora; J C Porres; C Hernández Guio; J Gutiez; Vicente Carreño
Hemagglutination and immunofluorescence studies on polymerized human serum albumin binding activity in chronic hepatitis B virus infection.
Hepatology (Baltimore, Md.) 1986;6(1):14-9.
1985: Juan A Quiroga; O González; Vicente Carreño; I Mora; J C Porres; J Gutiez; C Hernández-Guío
Radioimmunoassay for detecting hepatitis B core antigen in serum from patients with chronic hepatitis B infection.
Clinical chemistry 1985;31(6):831-4.
1984: L Bas; Vicente Carreño; J C Porres; I Mora; J Gutiez; M de Torres; C Hernández Guio
[Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
Revista clínica española 1984;175(2):67-9.
1984: J C Porres; Vicente Carreño; C Hernández Guio
[Prospective study of A, B, and non-A, non-B acute hepatitis: epidemiologic and clinical differences].
Revista clínica española 1984;174(1-2):31-4.